These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 7781682

  • 21. Streptozotocin-induced diabetes selectively enhances antinociception mediated by delta 1- but not delta 2-opioid receptors.
    Kamei J, Iwamoto Y, Misawa M, Nagase H, Kasuya Y.
    Life Sci; 1994; 55(6):PL121-6. PubMed ID: 8035657
    [Abstract] [Full Text] [Related]

  • 22. Effects of diabetes on the antinociceptive effect of (+/-)pentazocine in mice.
    Kamei J, Iwamoto Y, Misawa M, Nagase H, Kasuya Y.
    Res Commun Chem Pathol Pharmacol; 1994 Apr; 84(1):105-10. PubMed ID: 8042002
    [Abstract] [Full Text] [Related]

  • 23. Antinociceptive effects of the ORL1 receptor agonist nociceptin/orphanin FQ in diabetic mice.
    Kamei J, Ohsawa M, Kashiwazaki T, Nagase H.
    Eur J Pharmacol; 1999 Apr 09; 370(2):109-16. PubMed ID: 10323258
    [Abstract] [Full Text] [Related]

  • 24. Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice.
    Broom DC, Nitsche JF, Pintar JE, Rice KC, Woods JH, Traynor JR.
    J Pharmacol Exp Ther; 2002 Nov 09; 303(2):723-9. PubMed ID: 12388657
    [Abstract] [Full Text] [Related]

  • 25. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
    Suzuki T, Mori T, Tsuji M, Maeda J, Kishimoto Y, Misawa M, Nagase H.
    Eur J Pharmacol; 1997 Apr 11; 324(1):21-9. PubMed ID: 9137909
    [Abstract] [Full Text] [Related]

  • 26. The pharmacological profile of delta opioid receptor ligands, (+) and (-) TAN-67 on pain modulation.
    Nagase H, Yajima Y, Fujii H, Kawamura K, Narita M, Kamei J, Suzuki T.
    Life Sci; 2001 Apr 06; 68(19-20):2227-31. PubMed ID: 11358331
    [Abstract] [Full Text] [Related]

  • 27. N-cyclobutylmethyl analog of normorphinone, N-CBM-TAMO: a short-term opioid agonist and long-term Mu-selective irreversible opioid antagonist.
    Xu JY, Seyed-Mozaffari A, Archer S, Bidlack JM.
    J Pharmacol Exp Ther; 1996 Nov 06; 279(2):539-47. PubMed ID: 8930155
    [Abstract] [Full Text] [Related]

  • 28. Buprenorphine exerts its antinociceptive activity via mu 1-opioid receptors.
    Kamei J, Saitoh A, Suzuki T, Misawa M, Nagase H, Kasuya Y.
    Life Sci; 1995 Mar 03; 56(15):PL285-90. PubMed ID: 8614238
    [Abstract] [Full Text] [Related]

  • 29. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL, Bartlett JL, Ananthan S, Bilsky EJ.
    J Pharmacol Exp Ther; 2001 May 03; 297(2):597-605. PubMed ID: 11303048
    [Abstract] [Full Text] [Related]

  • 30. The novel δ opioid receptor agonist KNT-127 produces antidepressant-like and antinociceptive effects in mice without producing convulsions.
    Saitoh A, Sugiyama A, Nemoto T, Fujii H, Wada K, Oka J, Nagase H, Yamada M.
    Behav Brain Res; 2011 Oct 01; 223(2):271-9. PubMed ID: 21565223
    [Abstract] [Full Text] [Related]

  • 31. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
    Negri L, Improta G, Lattanzi R, Potenza RL, Luchetti F, Melchiorri P.
    Br J Pharmacol; 1995 Dec 01; 116(7):2931-8. PubMed ID: 8680727
    [Abstract] [Full Text] [Related]

  • 32. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J, Ohhashi Y, Aoki T, Kawasima N, Kasuya Y.
    Brain Res; 1992 Feb 07; 571(2):199-203. PubMed ID: 1319265
    [Abstract] [Full Text] [Related]

  • 33. Properties of TAN-67, a nonpeptidic delta-opioid receptor agonist, at cloned human delta- and mu-opioid receptors.
    Knapp RJ, Landsman R, Waite S, Malatynska E, Varga E, Haq W, Hruby VJ, Roeske WR, Nagase H, Yamamura HI.
    Eur J Pharmacol; 1995 Oct 15; 291(2):129-34. PubMed ID: 8566162
    [Abstract] [Full Text] [Related]

  • 34. Unexpected antinociceptive potency of cyclic [D-Tca1]CTAP: potential for a novel mechanism of action.
    Horan PJ, Wild KD, Kazmierski WM, Ferguson R, Hruby VJ, Weber SJ, Davis TP, Fang L, Knapp RJ, Yamamura HI.
    Eur J Pharmacol; 1993 Mar 16; 233(1):53-62. PubMed ID: 8386089
    [Abstract] [Full Text] [Related]

  • 35. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK, Meert TF.
    J Pharmacol Exp Ther; 2002 Sep 16; 302(3):1253-64. PubMed ID: 12183687
    [Abstract] [Full Text] [Related]

  • 36. Differential mediation of cold water swim stress-induced antinociception by delta-opioid receptor subtypes in diabetic mice.
    Kamei J, Iwamoto Y, Hitosugi H, Misawa M, Nagase H, Kasuya Y.
    Life Sci; 1994 Sep 16; 54(23):PL425-30. PubMed ID: 8196487
    [Abstract] [Full Text] [Related]

  • 37. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
    Ward SJ, Takemori AE.
    J Pharmacol Exp Ther; 1983 Mar 16; 224(3):525-30. PubMed ID: 6131119
    [Abstract] [Full Text] [Related]

  • 38. Antinociceptive profile of biphalin, a dimeric enkephalin analog.
    Horan PJ, Mattia A, Bilsky EJ, Weber S, Davis TP, Yamamura HI, Malatynska E, Appleyard SM, Slaninova J, Misicka A.
    J Pharmacol Exp Ther; 1993 Jun 16; 265(3):1446-54. PubMed ID: 8389867
    [Abstract] [Full Text] [Related]

  • 39. The role of delta-opioid receptors in the discriminative stimulus properties of a low dose of methamphetamine.
    Suzuki T, Mori T, Tsuji M, Misawa M, Nagase H.
    Eur J Pharmacol; 1997 Jul 16; 331(1):1-8. PubMed ID: 9274922
    [Abstract] [Full Text] [Related]

  • 40. ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides.
    Lohmann AB, Welch SP.
    Eur J Pharmacol; 1999 Dec 03; 385(2-3):119-27. PubMed ID: 10607867
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.